首页> 美国卫生研究院文献>Molecular Syndromology >Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions
【2h】

Identification of Nine New RAI1-Truncating Mutations in Smith-Magenis Syndrome Patients without 17p11.2 Deletions

机译:没有删除17p11.2的史密斯-马格尼斯综合征患者中的九个新的RAI1截短突变的鉴定。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Smith-Magenis syndrome (SMS) is an intellectual disability syndrome with sleep disturbance, self-injurious behaviors and dysmorphic features. It is estimated to occur in 1/25,000 births, and in 90% of cases it is associated with interstitial deletions of chromosome 17p11.2. RAI1 (retinoic acid induced 1; OMIM 607642) mutations are the second most frequent molecular etiology, with this gene being located in the SMS locus at 17p11.2. Here, we report 9 new RAI1-truncating mutations in nonrelated individuals referred for molecular analysis due to a possible SMS diagnosis. None of these patients carried a 17p11.2 deletion. The 9 mutations include 2 nonsense mutations and 7 heterozygous frameshift mutations leading to protein truncation. All mutations map in exon 3 of RAI1 which codes for more than 98% of the protein. RAI1 regulates gene transcription, and its targets are themselves involved in transcriptional regulation, cell growth and cell cycle regulation, bone and skeletal development, lipid and glucide metabolisms, neurological development, behavioral functions, and circadian activity. We report the clinical features of the patients carrying these deleterious mutations in comparison with those of patients carrying 17p11.2 deletions.
机译:Smith-Magenis综合征(SMS)是一种智力障碍综合征,具有睡眠障碍,自残行为和畸形特征。据估计,它发生在1 / 25,000例婴儿中,在90%的病例中,它与17p11.2号染色体的间质性缺失有关。 RAI1(视黄酸诱导1; OMIM 607642)突变是第二常见的分子病因,该基因位于SMS基因座中的17p11.2。在这里,由于可能的SMS诊断,我们报告了9个新的RAI1截短突变,这些突变涉及非相关个体进行分子分析。这些患者均未携带17p11.2缺失。 9个突变包括2个无意义的突变和7个导致蛋白质截断的杂合的移码突变。所有突变都位于RAI1外显子3中,该外显子编码该蛋白的98%以上。 RAI1调节基因转录,其靶标本身也参与转录调节,细胞生长和细胞周期调节,骨骼和骨骼发育,脂质和糖代谢,神经系统发育,行为功能和昼夜节律活动。我们报告携带这些有害突变的患者与携带17p11.2缺失的患者的临床特征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号